Tuesday, November 12, 2019
- 9:00AM-11:00AM
-
Abstract Number: 2025
Ancestry Influences the Gene Expression Profile in Systemic Lupus Erythematosus and Contributes to Transcriptomic Heterogeneity in Lupus Patients
SLE – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2609
Anti-angiogenic VEGF-A165b Is Associated with Systemic Sclerosis Peripheral Vasculopathy
Systemic Sclerosis & Related Disorders – Clinical Poster III- 9:00AM-11:00AM
-
Abstract Number: 2000
Anti-inflammatory Effect of Novel Spleen Tyrosine Kinase Inhibitor, SKI-O-592, on Fibroblast-like Synoviocyte in Rheumatoid Arthritis and THP-1 Cell
RA – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2003
Anti-Polygalacturonic Acid Antibody (PGA-Ab) Induced Bone Destruction in Rheumatoid Arthritis by Promoting Osteoclastogenesis via Integrin Beta 5
RA – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2618
Anti-RNPC-3 Antibodies Are Associated with Nuclear Speckled Immunofluorescence Pattern and Enriched in Triple Negative Systemic Sclerosis Patients
Systemic Sclerosis & Related Disorders – Clinical Poster III- 9:00AM-11:00AM
-
Abstract Number: 2103
Anti-TNF Therapy in Patients with HIV Infection
Infection-Related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 2297
Anti-TNF-α Exposure During Pregnancy: Impact on the Neonate’s Immune System
Reproductive Issues In Rheumatic Disorders Poster- 9:00AM-11:00AM
-
Abstract Number: 2128
Anti–MDA5 Antibody Positive Dermatomyositis Is Not Always Associated with Recalcitrant Lung Disease or Mortality
Miscellanous Rheumatic & Inflammatory Disease Poster III: Autoimmune Conditions and Therapies- 9:00AM-11:00AM
-
Abstract Number: 2038
Antibodies to Malondialdehyde-acetaldehyde (MAA) Protein Adduct as a Biomarker for Cardiovascular Manifestations in Systemic Lupus Erythematosus
SLE – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2526
Antimalarial Agents Improve Physical Functioning in Patients with Systemic Lupus Erythematosus
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2555
Antimalarial-Induced Cardiomyopathy: Outcome in 10 Patients
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2355
Antirheumatic Therapy Is Associated with Reduced Complement Activation in Rheumatoid Arthritis
RA – Treatments Poster III: Safety and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 2356
Antirheumatic Therapy Is Not Associated with Changes in Circulating N-terminal Pro-brain Natriuretic Peptide Levels in Patients with Active Rheumatoid Arthritis
RA – Treatments Poster III: Safety and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1950
Apolipoprotein L1 Variant-Carrying Monocytes Exhibit Mitochondrial Respiration Defects
Genetics, Genomics & Proteomics Poster- 9:00AM-11:00AM
-
Abstract Number: 2230
Applicability of FRAX in Clinical Practice: 10-year Results